Reviews - 2qri mentioned but not cited (1)
- Properties and applications of single-chain major histocompatibility complex class I molecules. Kotsiou E, Brzostek J, Gould KG. Antioxid Redox Signal 15 645-655 (2011)
Articles - 2qri mentioned but not cited (1)
- The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1. Papakyriakou A, Reeves E, Beton M, Mikolajek H, Douglas L, Cooper G, Elliott T, Werner JM, James E. J Biol Chem 293 7538-7548 (2018)
Reviews citing this publication (2)
- Basic and translational applications of engineered MHC class I proteins. Hansen TH, Connolly JM, Gould KG, Fremont DH. Trends Immunol 31 363-369 (2010)
- T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy. Duan Z, Ho M. Mol Cancer Ther 20 1533-1541 (2021)
Articles citing this publication (35)
- PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways. Zhao Y, Lee CK, Lin CH, Gassen RB, Xu X, Huang Z, Xiao C, Bonorino C, Lu LF, Bui JD, Hui E. Immunity 51 1059-1073.e9 (2019)
- Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells. Zhao Y, Harrison DL, Song Y, Ji J, Huang J, Hui E. Cell Rep 24 379-390.e6 (2018)
- Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity. Adams JJ, Narayanan S, Birnbaum ME, Sidhu SS, Blevins SJ, Gee MH, Sibener LV, Baker BM, Kranz DM, Garcia KC. Nat Immunol 17 87-94 (2016)
- Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove. McMurtrey C, Trolle T, Sansom T, Remesh SG, Kaever T, Bardet W, Jackson K, McLeod R, Sette A, Nielsen M, Zajonc DM, Blader IJ, Peters B, Hildebrand W. Elife 5 e12556 (2016)
- Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination. Li L, Kim S, Herndon JM, Goedegebuure P, Belt BA, Satpathy AT, Fleming TP, Hansen TH, Murphy KM, Gillanders WE. Proc Natl Acad Sci U S A 109 12716-12721 (2012)
- A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire. Wang B, Primeau TM, Myers N, Rohrs HW, Gross ML, Lybarger L, Hansen TH, Connolly JM. Science 326 871-874 (2009)
- HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities. Yang H, Rei M, Brackenridge S, Brenna E, Sun H, Abdulhaqq S, Liu MKP, Ma W, Kurupati P, Xu X, Cerundolo V, Jenkins E, Davis SJ, Sacha JB, Früh K, Picker LJ, Borrow P, Gillespie GM, McMichael AJ. Sci Immunol 6 eabg1703 (2021)
- Natural killer cell licensing in mice with inducible expression of MHC class I. Ebihara T, Jonsson AH, Yokoyama WM. Proc Natl Acad Sci U S A 110 E4232-7 (2013)
- TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex. Coles CH, Mulvaney RM, Malla S, Walker A, Smith KJ, Lloyd A, Lowe KL, McCully ML, Martinez Hague R, Aleksic M, Harper J, Paston SJ, Donnellan Z, Chester F, Wiederhold K, Robinson RA, Knox A, Stacey AR, Dukes J, Baston E, Griffin S, Jakobsen BK, Vuidepot A, Harper S. J Immunol 204 1943-1953 (2020)
- Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen. Poole A, Karuppiah V, Hartt A, Haidar JN, Moureau S, Dobrzycki T, Hayes C, Rowley C, Dias J, Harper S, Barnbrook K, Hock M, Coles C, Yang W, Aleksic M, Lin AB, Robinson R, Dukes JD, Liddy N, Van der Kamp M, Plowman GD, Vuidepot A, Cole DK, Whale AD, Chillakuri C. Nat Commun 13 5333 (2022)
- Soluble T-cell receptors produced in human cells for targeted delivery. Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J. PLoS One 10 e0119559 (2015)
- Cancer genome sequencing and its implications for personalized cancer vaccines. Li L, Goedegebuure P, Mardis ER, Ellis MJ, Zhang X, Herndon JM, Fleming TP, Carreno BM, Hansen TH, Gillanders WE. Cancers (Basel) 3 4191-4211 (2011)
- Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides. Truscott SM, Wang X, Lybarger L, Biddison WE, McBerry C, Martinko JM, Connolly JM, Linette GP, Fremont DH, Hansen TH, Carreno BM. J Biol Chem 283 7480-7490 (2008)
- Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells. Samanta D, Mukherjee G, Ramagopal UA, Chaparro RJ, Nathenson SG, DiLorenzo TP, Almo SC. Proc Natl Acad Sci U S A 108 13682-13687 (2011)
- Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens. Li L, Herndon JM, Truscott SM, Hansen TH, Fleming TP, Goedegebuure P, Gillanders WE. Vaccine 28 1911-1918 (2010)
- A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice. Kim S, Pinto AK, Myers NB, Hawkins O, Doll K, Kaabinejadian S, Netland J, Bevan MJ, Weidanz JA, Hildebrand WH, Diamond MS, Hansen TH. Eur J Immunol 44 1936-1946 (2014)
- T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice. Li M, Garforth SJ, O'Connor KE, Su H, Lee DM, Celikgil A, Chaparro RJ, Seidel RD, Jones RB, Arav-Boger R, Almo SC, Goldstein H. J Clin Invest 131 e141051 (2021)
- A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement. Wang X, Piersma SJ, Nelson CA, Dai YN, Christensen T, Lazear E, Yang L, Sluijter M, van Hall T, Hansen TH, Yokoyama WM, Fremont DH. Elife 7 e38667 (2018)
- Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM. Saotome K, Dudgeon D, Colotti K, Moore MJ, Jones J, Zhou Y, Rafique A, Yancopoulos GD, Murphy AJ, Lin JC, Olson WC, Franklin MC. Nat Commun 14 2401 (2023)
- Cross-recognition of a myelin peptide by CD8+ T cells in the CNS is not sufficient to promote neuronal damage. Reuter E, Gollan R, Grohmann N, Paterka M, Salmon H, Birkenstock J, Richers S, Leuenberger T, Brandt AU, Kuhlmann T, Zipp F, Siffrin V. J Neurosci 35 4837-4850 (2015)
- Kinase suppressor of Ras 1 is not required for the generation of regulatory and memory T cells. Le Borgne M, Filbert EL, Shaw AS. PLoS One 8 e57137 (2013)
- DC-expressed MHC class I single-chain trimer-based vaccines prime cytotoxic T lymphocytes against exogenous but not endogenous antigens. Ordaz ML, Larmonier N, Lybarger L. Cell Immunol 262 141-149 (2010)
- Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines. Wooster AL, Anderson TS, Lowe DB. J Immunol Methods 464 22-30 (2019)
- Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA. Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J. Oncoimmunology 5 e1138199 (2016)
- Amino-terminal extended peptide single-chain trimers are potent synthetic agonists for memory human CD8+ T cells. Carreno BM, Becker-Hapak M, Chan M, Lie WR, Wang X, Hansen TH, Linette GP. J Immunol 188 5839-5849 (2012)
- Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection. Kim S, Zuiani A, Carrero JA, Hansen TH. Vaccine 30 2178-2186 (2012)
- Antigen-guided depletion of anti-HLA antibody-producing cells by HLA-Fc fusion proteins. Webber AM, Bradstreet TR, Wang X, Guo H, Nelson CA, Fremont DH, Edelson BT, Liu C. Blood 140 1803-1815 (2022)
- Effects of HLA single chain trimer design on peptide presentation and stability. Finton KAK, Rupert PB, Friend DJ, Dinca A, Lovelace ES, Buerger M, Rusnac DV, Foote-McNabb U, Chour W, Heath JR, Campbell JS, Pierce RH, Strong RK. Front Immunol 14 1170462 (2023)
- Intrinsic Folding Properties of the HLA-B27 Heavy Chain Revealed by Single Chain Trimer Versions of Peptide-Loaded Class I Major Histocompatibility Complex Molecules. Lenart I, Truong LH, Nguyen DD, Rasiukienė O, Tsao E, Armstrong J, Kumar P, McHugh K, Pereira BI, Maan BS, Garstka MA, Bowness P, Blake N, Powis SJ, Gould K, Nesbeth D, Antoniou AN. Front Immunol 13 902135 (2022)
- Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Chour W, Choi J, Xie J, Chaffee ME, Schmitt TM, Finton K, DeLucia DC, Xu AM, Su Y, Chen DG, Zhang R, Yuan D, Hong S, Ng AHC, Butler JZ, Edmark RA, Jones LC, Murray KM, Peng S, Li G, Strong RK, Lee JK, Goldman JD, Greenberg PD, Heath JR. Commun Biol 6 528 (2023)
- MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection. Meyer M, Parpoulas C, Barthélémy T, Becker JP, Charoentong P, Lyu Y, Börsig S, Bulbuc N, Tessmer C, Weinacht L, Ibberson D, Schmidt P, Pipkorn R, Eichmüller SB, Steinberger P, Lindner K, Poschke I, Platten M, Fröhling S, Riemer AB, Hassel JC, Roberti MP, Jäger D, Zörnig I, Momburg F. Front Immunol 14 1294565 (2023)
- Dimerization of soluble disulfide trap single-chain major histocompatibility complex class I molecules dependent on peptide binding affinity. Kotsiou E, Brzostek J, Lenart I, Antoniou AN, Dyson J, Gould KG. Antioxid Redox Signal 15 635-644 (2011)
- Interchain disulfide engineering enables the efficient production of functional HLA-DQ-Fc fusion proteins. Aisihaer X, Guo H, Liu C. J Biol Chem 300 107652 (2024)
- Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes. Sharma R, Amdare NP, Ghosh A, Schloss J, Sidney J, Garforth SJ, Lopez Y, Celikgil A, Sette A, Almo SC, DiLorenzo TP. J Biol Chem 300 107702 (2024)
- optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material. Salek M, Förster JD, Becker JP, Meyer M, Charoentong P, Lyu Y, Lindner K, Lotsch C, Volkmar M, Momburg F, Poschke I, Fröhling S, Schmitz M, Offringa R, Platten M, Jäger D, Zörnig I, Riemer AB. Mol Cell Proteomics 23 100825 (2024)